Brief: Pacira Biosciences Q3 Adjusted Net Income USD 38.2 Million Vs. IBES Estimate USD 34.9 Million
06/11/2024 21:00
Nov 06 (Reuters) - Pacira Biosciences Q3 revenue USD 168.6 million vs. IBES estimate USD 169.7 million. * Q3 cash & investments USD 453.8 million * Q3 adjusted EBITDA USD 54.7 million vs. IBES estimate USD 51.8 million * Q3 net income USD -143.5 million
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal